Cidara Therapeutics Inc

CDTX's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

CDTX Growth rates comparisons

Cidara Therapeutics Inc 's sales fell in the third quarter of 2025 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 3.51 %

Cidara Therapeutics Inc net loss decreased from $-91 millions, to $-83 millions in third quarter of 2025,

• More on CDTX's Growth

CDTX's Valuation comparisons

Cidara Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 34.28 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.36.

• More on CDTX's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	15.71

CDTX's Valuation comparisons

Cidara Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 34.28 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.36.

Cidara Therapeutics Inc Price to Book Ratio is at 14.01 lower than Industry Avg. of 1638.9. and higher than S&P 500 Avg. of 0.02

• More on CDTX's Valuation

• Market Capitalization (Millions $)	5,916
• Shares Outstanding (Millions)	27
• Employees	50
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-148
• Cash Flow (TTM) (Millions $)	173
• Capital Exp. (TTM) (Millions $)	-
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	15.71

• Market Capitalization (Millions $)	5,916
• Shares Outstanding (Millions)	27
• Employees	50
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-148
• Cash Flow (TTM) (Millions $)	173
• Capital Exp. (TTM) (Millions $)	-

	*Ratio*
• Capital Ratio (MRQ)	4.62
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	0.23
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

CDTX's Profitability Comparisons

• More on CDTX's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.